Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 180

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial

Open access
Wittekamp, Bastiaan H., Plantinga, Nienke L., Cooper, Ben S., Lopez-Contreras, Joaquin, Coll, Pere, Mancebo, Jordi, Wise, Matt P., Morgan, Matt P. G., Depuydt, Pieter, Boelens, Jerina, Dugernier, Thierry, Verbelen, Valérie, Jorens, Philippe G., Verbrugghe, Walter, Malhotra-Kumar, Surbhi, Damas, Pierre, Meex, Cécile, Leleu, Kris, van den Abeele, Anne-Marie, Gomes Pimenta de Matos, Ana Filipa, Fernández Méndez, Sara, Vergara Gomez, Andrea, Tomic, Viktorija, Sifrer, Franc, Villarreal Tello, Esther, Ruiz Ramos, Jesus, Aragao, Irene, Santos, Claudia, Sperning, Roberta H. M., Coppadoro, Patrizia, Nardi, Giuseppe, Brun-Buisson, Christian, Bonten, Marc J. M. · 2018 · JAMA

Abstract

Importance: The effects of chlorhexidine (CHX) mouthwash, selective oropharyngeal decontamination (SOD), and selective digestive tract decontamination (SDD) on patient outcomes in ICUs with moderate to high levels of antibiotic resistance are unknown. Objective: To determine associations between CHX 2%, SOD, and SDD and the occurrence of ICU-acquired bloodstream infections with multidrug-resistant gram-negative bacteria (MDRGNB) and 28-day mortality in ICUs with moderate to high levels of antibiotic resistance. Design, Setting, and Participants: Randomized trial conducted from December 1, 2013, to May 31, 2017, in 13 European ICUs where at least 5% of bloodstream infections are caused by extended-spectrum β-lactamase-producing Enterobacteriaceae. Patients with anticipated mechanical ventilation of more than 24 hours were eligible. The final date of follow-up was September 20, 2017. Interventions: Standard care was daily CHX 2% body washings and a hand hygiene improvement program. Following a baseline period from 6 to 14 months, each ICU was assigned in random order to 3 separate 6-month intervention periods with either CHX 2% mouthwash, SOD (mouthpaste with colistin, tobramycin, and nystatin), or SDD (the same mouthpaste and gastrointestinal suspension with the same antibiotics), all applied 4 times daily. Main Outcomes and Measures: The occurrence of ICU-acquired bloodstream infection with MDRGNB (primary outcome) and 28-day mortality (secondary outcome) during each intervention period compared with the baseline period. Results: A total of 8665 patients (median age, 64.1 years; 5561 men [64.2%]) were included in the study (2251, 2108, 2224, and 2082 in the baseline, CHX, SOD, and SDD periods, respectively). ICU-acquired bloodstream infection with MDRGNB occurred among 144 patients (154 episodes) in 2.1%, 1.8%, 1.5%, and 1.2% of included patients during the baseline, CHX, SOD, and SDD periods, respectively. Absolute risk reductions were 0.3% (95% CI, -0.6% to 1.1%), 0.6% (95% CI, -0.2% to 1.4%), and 0.8% (95% CI, 0.1% to 1.6%) for CHX, SOD, and SDD, respectively, compared with baseline. Adjusted hazard ratios were 1.13 (95% CI, 0.68-1.88), 0.89 (95% CI, 0.55-1.45), and 0.70 (95% CI, 0.43-1.14) during the CHX, SOD, and SDD periods, respectively, vs baseline. Crude mortality risks on day 28 were 31.9%, 32.9%, 32.4%, and 34.1% during the baseline, CHX, SOD, and SDD periods, respectively. Adjusted odds ratios for 28-day mortality were 1.07 (95% CI, 0.86-1.32), 1.05 (95% CI, 0.85-1.29), and 1.03 (95% CI, 0.80-1.32) for CHX, SOD, and SDD, respectively, vs baseline. Conclusions and Relevance: Among patients receiving mechanical ventilation in ICUs with moderate to high antibiotic resistance prevalence, use of CHX mouthwash, SOD, or SDD was not associated with reductions in ICU-acquired bloodstream infections caused by MDRGNB compared with standard care. Trial Registration: ClinicalTrials.gov Identifier: NCT02208154.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2018.13765

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 180

Metadata

Authors
Wittekamp, B. H., Plantinga, N. L., Cooper, B. S., Lopez-Contreras, J., Coll, P., Mancebo, J., Wise, M. P., Morgan, M. P. G., Depuydt, P., Boelens, J., Dugernier, T., Verbelen, V., Jorens, P. G., Verbrugghe, W., Malhotra-Kumar, S., Damas, P., Meex, C., Leleu, K., van den Abeele, A.-M., Gomes Pimenta de Matos, A. F., Fernández Méndez, S., Vergara Gomez, A., Tomic, V., Sifrer, F., Villarreal Tello, E., Ruiz Ramos, J., Aragao, I., Santos, C., Sperning, R. H. M., Coppadoro, P., Nardi, G., Brun-Buisson, C., & Bonten, M. J. M.
Venue
JAMA
Published
2018-11-27
Volume
320
Issue
20
Pages
2087
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2896346062
Cited by
180
References
3
FWCI
13.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2018.13765
The paper
Wittekamp, B. H., Plantinga, N. L., Cooper, B. S., Lopez-Contreras, J., Coll, P., Mancebo, J., Wise, M. P., Morgan, M. P. G., Depuydt, P., Boelens, J., Dugernier, T., Verbelen, V., Jorens, P. G., Verbrugghe, W., Malhotra-Kumar, S., Damas, P., Meex, C., Leleu, K., van den Abeele, A.-M., . . . Bonten, M. J. M. (2018). Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2018.13765

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.